We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
601
United Therapeutics
UTHR
$26.3B
$15.1M 0.02%
99,618
+190
+0.2% +$24.9K
FDX icon
602
FedEx
FDX
$73.5B
$15.1M 0.02%
58,123
+1,703
+3% +$472K
EME icon
603
Emcor
EME
$33B
$15M 0.02%
163,939
-6,000
-4% -$482K
EPD icon
604
Enterprise Products Partners
EPD
$82.5B
$14.9M 0.02%
762,404
-36,723
-5% -$684K
PNC icon
605
PNC Financial Services
PNC
$99.6B
$14.9M 0.02%
99,790
-186,025
-65% -$23.8M
KNX icon
606
Knight Transportation
KNX
$11.5B
$14.7M 0.02%
352,590
-151,825
-30% -$6.19M
DOCU
607
DocuSign
DOCU
$10.1B
$14.7M 0.02%
66,045
-18,302
-22% -$4.11M
GTES icon
608
Gates Industrial Corporation Ltd.
GTES
$6.72B
$14.6M 0.02%
1,146,630
-66,468
-5% -$832K
BWXT icon
609
BWX Technologies
BWXT
$16.2B
$14.6M 0.02%
242,202
+144,691
+148% +$8.34M
CERN
610
DELISTED
Cerner Corp
CERN
$14.6M 0.02%
185,633
+165,255
+811% +$12.2M
PPL
611
PPL Corp
PPL
$27.1B
$14.5M 0.02%
514,257
+20,772
+4% +$590K
VEA icon
612
Vanguard FTSE Developed Markets ETF
VEA
$227B
$14.4M 0.02%
+306,050
New +$13.5M
ITCI
613
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$14.4M 0.02%
452,890
TKC icon
614
Turkcell
TKC
$4.79B
$14.3M 0.02%
2,644,129
-5,638
-0.2% -$28.4K
ALSN icon
615
Allison Transmission
ALSN
$10.1B
$14.2M 0.02%
328,816
-21,200
-6% -$852K
AVT icon
616
Avnet
AVT
$7.25B
$14.1M 0.02%
401,194
-31,700
-7% -$941K
SLGN icon
617
Silgan Holdings
SLGN
$4.92B
$14.1M 0.02%
379,069
+350,564
+1,230% +$12.6M
AAP icon
618
Advance Auto Parts
AAP
$3.48B
$14M 0.02%
89,092
-2,980
-3% -$460K
KSU
619
DELISTED
Kansas City Southern
KSU
$14M 0.02%
68,554
-13,284
-16% -$2.49M
NEM icon
620
Newmont
NEM
$98.5B
$13.9M 0.02%
232,597
-59,067
-20% -$3.64M
RDFN
621
DELISTED
Redfin
RDFN
$13.9M 0.02%
202,595
-50,479
-20% -$2.7M
IQV icon
622
IQVIA
IQV
$35.6B
$13.7M 0.02%
76,597
-698,229
-90% -$118M
VLO icon
623
Valero Energy
VLO
$90.5B
$13.7M 0.02%
242,546
+7,454
+3% +$366K
MCK icon
624
McKesson
MCK
$99.5B
$13.7M 0.02%
78,711
-1,540
-2% -$256K
TDY icon
625
Teledyne Technologies
TDY
$30.2B
$13.6M 0.02%
34,745
+15,826
+84% +$5.68M

Similar funds

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.